Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole effect on BI 3031185 pharmacokinetics in healthy volunteers
NCT07211425Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BI 3031185, sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve of BI 3031185 in plasma over the time interval from 0 to the last quantifiable data point at Day 13 and Maximum measured concentration of BI 3031185 in plasma at Day 13. Started Oct 2025; status: completed.
02
Drugs
BI 3031185
Beyond the preview
Go deeper on NCT07211425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211425.